Skip to main content
NGEN logo

NGEN

Nervgen Pharma Corp.
$2.12 +0.03 (+1.44%) At close · Jul 2
Market Cap
$225.15M
Shares
79,649,257

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 45
Total Value: $6,383,890
Total Shares: 1,693,343

Institutional Ownership Trend

14 quarters

Holder Concentration

Across 45 13F filers · Δ vs Dec 31, 2025
Top Holder
11.9%
Dec 2021 → Mar 2026 · range 11.9% – 100.0%
−88.1 pts
Top 5
50.8%
Dec 2021 → Mar 2026 · range 50.8% – 100.0%
−49.2 pts
Top 10
68.8%
Dec 2021 → Mar 2026 · range 68.8% – 100.0%
−31.2 pts
HHI
658
Dec 2021 → Mar 2026 · range 658 – 10,000
Broadly held−9,342

Quarterly Activity

vs Dec 31, 2025
New
44
Increased
0
Decreased
0
Sold Out
0
Unchanged
1
Holder count: +44
Institutional value: +11299.8%
Shares held: +16833.4%

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
No fully closed positions this quarter.
Showing 45 of 45
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1751912 CUSIP 64082X203 13F (30d) 2 filings 1 filers Visit website